Mestag Therapeutics has dosed the first patient in its Phase [...]

AstraZeneca’s Imfinzi (durvalumab) has been recommended by NICE for use [...]

Grow Therapy has published its first peer-reviewed outcomes study, reporting [...]

Japan’s push to modernise clinical research through artificial intelligence and [...]

The Longitude Prize on ALS has awarded £2 million to [...]

Researchers at the University of Huddersfield have won two prizes [...]

Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]

Alto Neuroscience has started a Phase 2b trial of ALTO-207 [...]

ARTCLINE has completed patient enrolment in a 142-patient randomized study [...]